Universal Health Realty Income Trust
NYSE:UHTREIT - Healthcare Facilities
+$0.05 today
- Market cap
- $533.33M
- Beta
- 0.86
- P/E (TTM)
- 30.1
- EPS (TTM)
- $1.29
- Dividend yield
- 7.65%
Volume 0.15M
Average 0.08M
UHT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Universal Health Realty Income TrustNYSE: UHT
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How UHT compares with its peers on the latest reported figures
- UHT's LTM Mar 2026 research & development of $0 is the highest of the 9 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for UHT, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
ADAMAdamas Trust, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding UHT) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for UHT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 84.19M | 90.63M | 95.58M | 99.01M | 99.19M |
| Cost of Revenue | 4.41M | 5.1M | 5.32M | 5.48M | 5.6M |
| Gross Profit | 79.78M | 85.53M | 90.25M | 93.53M | 93.6M |
| Gross Margin | 94.8% | 94.4% | 94.4% | 94.5% | 94.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 50.92M | 54.86M | 58.9M | 56.73M | 58.83M |
| Depreciation & Amortization | 27.48M | 26.56M | 27.73M | 27.42M | 28.86M |
| EBITDA | 145.45M | 58.41M | 65.16M | 70.49M | 67.58M |
| EBITDA Margin | 172.8% | 64.5% | 68.2% | 71.2% | 68.1% |
| Operating Income | 28.87M | 30.67M | 31.35M | 36.8M | 34.76M |
| Operating Margin | 34.3% | 33.8% | 32.8% | 37.2% | 35.0% |
| Interest Income | 51K | 1.02M | 5.84M | 5.76M | 5.4M |
| Interest Expense | 8.81M | 10.76M | 22.03M | 23.83M | 21.87M |
| Other Income / Expenses | 80.3M | (9.56M) | (15.95M) | (17.56M) | (17.15M) |
| Income Before Tax | 109.17M | 21.1M | 15.4M | 19.23M | 17.61M |
| Pre-Tax Margin | 129.7% | 23.3% | 16.1% | 19.4% | 17.8% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 109.17M | 21.1M | 15.4M | 19.23M | 17.61M |
| Net Margin | 129.7% | 23.3% | 16.1% | 19.4% | 17.8% |
| EPS (Basic) | 7.94 | 1.53 | 1.12 | 1.39 | 1.27 |
| EPS (Diluted) | 7.92 | 1.53 | 1.11 | 1.39 | 1.27 |
| Weighted Avg Shares | 13.76M | 13.77M | 13.79M | 13.8M | 13.82M |
| Weighted Avg Shares (Diluted) | 13.78M | 13.8M | 13.81M | 13.84M | 13.86M |
Universal Health Realty Income Trust
NYSE:UHT
Intrinsic Alpha fair value
Locked
Current Price
$38.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.